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Velamentous and marginal cord insertion and the risk of adverse pregnancy outcomes in singleton pregnancies Objectives: Anomalous cord insertion is associated to risk of adverse perinatal outcomes. The aim of this study was to determine the prevalence of anomalous umbilical cord insertions, and the risk for adverse perinatal outcomes. Methods: In this prospective study were considered 700 consecutive singleton pregnancies, 174 with marginal and 16 with velamentous cord insertion from January 2016 to January 2017. Neonatal outcome was available after delivery and perinatal outcome with different type of cord insertion has been analysed. The same consecutive cohort of placentas was analysed at the Surgical Pathology Unit at Padua University. The distance from the insertion site to the nearest placental edge was retrieved from the macroscopic description and was considered velamentous when inserting into the fetal membranes and marginal when it was below 2 centimetres.
Results: Mean gestational age was 37.46 weeks (±3.93), mean maternal age 33.57 years (±5.66), and mean neonatal weight was 3047.48gr (±716.85). No significant differences were found between gestational age at delivery and maternal age. The anomalous cord insertion was associated to lower neonatal weight. The prevalence of marginal cord insertion was 25% and 2.3%. for velamentous insertion. Velamentous cord insertion was associated to an increased risk of neonatal cardiopulmonary resuscitation (CRP) and neonatal intensive care unit (NICU) hospitalisation (p<0.05). Marginal cord insertion was associated to an increased risk of NICU hospitalisation (p<0.05).
Conclusions:
In this Cohort study of singleton pregnancies the prevalence of velamentous and marginal cord insertions were 2.3% and 25.0%; respectively. Velamentous cord insertion was associated with a worse neonatal outcome.
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Characteristics of fetal heart beat (FHB)-positive Caesarean scar pregnancy (CSP) and adverse effects of transarterial embolisation (TAE) therapy Objectives: Characteristics of fetal heart beat (FHB)-positive Caesarean scar pregnancy (CSP) depend on the development and prevalence of vaginal ultrasound, colour Doppler, and magnetic resonance imaging (MRI). This study aimed to identify FHB-positive CSP characteristics by reviewing cases that were previously reported in our country. We also aimed to determine adverse effects of transarterial embolisation (TAE) therapy. Methods: We searched articles using the key word ''Caesarean scar pregnancy'' from our national medical journal article retrieval system. We finally included 37 FHB-positive CSP cases and reviewed them. Results: FHB-positive CSP was present at the following gestational weeks: one case at 5 weeks' gestation, 13 cases at 6, 13 cases at 7, four cases at 8, four cases at 9, and two cases at 10. FHB-positive CSPs were treated with feticide, drug therapy, blood supply-decreasing techniques and operation. Only drug therapy was performed in 12 cases. Uterine preservation procedures (vaginal, laparoscopic, hysteroscopic and laparotomic resection) were performed in 19 cases. Hysterectomy was performed in six cases. Some patients had adverse effects of TAE in this series. A patient was administered with local MTX and general MTX. Massive vaginal bleeding then appeared and TAE was performed. Abdominal hysterectomy was performed because of uterine rupture and intrauterine infection. There were some adverse effects in the succeeding pregnancies in two cases. In one report, the succeeding pregnancy after TAE therapy showed placenta accreta vera and uterine perforation. In another article, the authors reported uterine rupture in the succeeding pregnancy at 32 weeks of gestation. Conclusions: A total of 70% of cases of CSP appeared at 6 and 7 weeks of gestation. Only medical treatment was performed in 32% (12/37) of all patients. Operative uterine-preserving procedures were performed in 51% (19/37) of all patients. TAE had the possibility of some adverse effects in this CSP and succeeding pregnancies.
